Famar was awarded by the National Kapodistrian University of Athens (EKPA), among other companies, for its long-term contribution to the Greek pharmaceutical industry and its progress.
At the special event held by EKPA in honor of the Pharmaceutical Industry in Greece, on Tuesday, January 24, Famar received an honorary plaque for its significant presence in domestic production, its overall contribution to public health, the national economy and employment as well as its continuous collaboration with the Academy and the Department of Pharmacy of EKPA.
The honorary plaque was received by Mr. Apostolos Sagiakos, CEO of Greece of the FAMAR Group.
In the context of the event, 21 pharmaceutical companies were honored for their long-term presence in the country and for their cooperation with the Department of Pharmacy of EKPA.
FAMAR has a 70-year track record of delivering quality and value to customers across all finished dosage forms including sterile liquids, solids, and semi-solids. FAMAR has a workforce of 1,850 employees across a network of six manufacturing sites and two R&D centres in Spain, Italy, and Greece.